Necessity of oligonucleotide aggregation for toll-like receptor 9 activation.
about
In vivo efficacy of a phosphodiester TLR-9 aptamer and its beneficial effect in a pulmonary anthrax infection modelSweeten PAMPs: Role of Sugar Complexed PAMPs in Innate Immunity and Vaccine Biology.Enzymatic synthesis of modified oligonucleotides by PEAR using Phusion and KOD DNA polymerases.Aggregation and secondary loop structure of oligonucleotides do not determine their ability to inhibit TLR9Use of thermolytic protective groups to prevent G-tetrad formation in CpG ODN type D: structural studies and immunomodulatory activity in primatesImmunotherapeutic activity of a conjugate of a Toll-like receptor 7 ligand.Structure-dependent modulation of alpha interferon production by porcine circovirus 2 oligodeoxyribonucleotide and CpG DNAs in porcine peripheral blood mononuclear cells.A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA.Development of Nonaggregating Poly-A Tailed Immunostimulatory A/D Type CpG Oligodeoxynucleotides Applicable for Clinical Use.A Toll for lupus.Immune mechanisms and therapeutic potential of CpG oligodeoxynucleotides.Prodrugs for the treatment of neglected diseases.Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancerBiomimetic protein nanoparticles facilitate enhanced dendritic cell activation and cross-presentation.RNA:DNA hybrids are a novel molecular pattern sensed by TLR9.CpG Type A Induction of an Early Protective Environment in Experimental Multiple Sclerosis.Cytotoxic G-rich oligodeoxynucleotides: putative protein targets and required sequence motif5'-Phosphate oligodeoxynucleotides enhance the phosphodiester-CpG DNA-induced inflammatory response in macrophages.Enhanced immunostimulatory activity of oligodeoxynucleotides by Y-shape formation.
P2860
Q33576071-D3955308-9E8F-45C4-BB20-F228B73DB50FQ34370741-CD7435C4-EFC6-4794-AABF-3FCB92482441Q34976847-19E89920-AFAC-4A55-A59B-5712A12DAEFEQ35058952-CB446F7D-2BDC-431E-84C9-AC0CC2659E15Q35225487-3FBFC60D-7945-4AE1-90A1-ED8941E677C2Q35676749-2BEA6C8F-77B1-4827-993E-0180508D94F1Q35857517-92B2E7E2-53C0-4376-83E5-4FF9336A2038Q35990737-7109A63D-18E7-4D28-AAEA-ACA0CF99A2CFQ36035012-07CD09EA-F2E6-4737-910F-BC1C22FA8C73Q36204298-5A377423-F58F-4C68-8848-B1E5D320846AQ36526351-CC318797-8DD3-46F9-867E-6417DED72395Q37157236-95568DA4-FA0B-4300-B74B-AC555D2BFF35Q37277677-EACD504F-807D-4C83-9045-CCB5254E9388Q37483316-D3EACDE1-4F08-40A5-8B43-F57D2707359CQ37707494-48F733A5-6131-4193-BC6A-FFF3585B4F17Q37710236-56217598-BCF0-414B-B256-39372A8B84E1Q38300600-34461614-5A4C-43C6-9D75-0C69EDBAFB09Q39602530-BFCD09C1-2BC2-46FB-B308-D12009F0E539Q40020895-76F4A117-C6D2-41FF-B393-DF51873FCA0E
P2860
Necessity of oligonucleotide aggregation for toll-like receptor 9 activation.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Necessity of oligonucleotide aggregation for toll-like receptor 9 activation.
@ast
Necessity of oligonucleotide aggregation for toll-like receptor 9 activation.
@en
type
label
Necessity of oligonucleotide aggregation for toll-like receptor 9 activation.
@ast
Necessity of oligonucleotide aggregation for toll-like receptor 9 activation.
@en
prefLabel
Necessity of oligonucleotide aggregation for toll-like receptor 9 activation.
@ast
Necessity of oligonucleotide aggregation for toll-like receptor 9 activation.
@en
P2093
P2860
P356
P1476
Necessity of oligonucleotide aggregation for toll-like receptor 9 activation.
@en
P2093
Christina C N Wu
Dennis A Carson
Jongdae Lee
Maripat Corr
P2860
P304
33071-33078
P356
10.1074/JBC.M311662200
P407
P577
2004-06-07T00:00:00Z